BRIEF-Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 – SEC Filing

3

Sept 21 (Reuters) – Recursion Pharmaceuticals, Inc. : * RECURSION PHARMACEUTICALS – ENTERS AMENDMENT TO MASTER AGREEMENT WITH TEMPUS ON SEPT 15, 2026 – SEC FILING * RECURSION PHARMACEUTICALS – EXTENDS

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)